Resources

Algorics launches MetaVate, metadata-driven automation for clinical data flow and transparency

As a leap forward, towards automating clinical data flow, Algorics has released version 2 of MetaVate, aimed at improving the... Read More

MetaVate: Redefining the future of programming

Download our brochure to learn how MetaVate supports any source to any target relational data transformation. Read More

Meet us at PharmaSUG 2022

We are excited to be a part of the PharmaSUG 2022 Conference coming up next week from May 22-25 in Austin, Texas. Read More

Join us at BioNJ's 12th Annual Biopartnering Conference

We are very excited for some great partnership discussions and working with emerging biotech to unpack the complexities of ea... Read More

Visualizing the patient journey

Oncology clinical trials have multitudes of challenges and given the duration and complexity, understanding, and visualizing ... Read More

Meet us at Phuse US Connect 2022

Are you going to be at Phuse US Connect 2022 from 1st to 4th May, in Atlanta? If you are and looking for future proof data sc... Read More

Algorics announces the launch of IDEAS solutions platform for emerging biotech companies

Algorics launches IDEAS solutions platform, enabling early-stage biotech companies harness the full power of clinical data. Read More

Accelerating early stage development with IDEAS

Download our brochure to learn how IDEAS enables biotechs accelerate early-stage development Read More

Embedded biostatistics and programming solutions for CROs

Download our flyer to learn more about how we can help. Read More

Know More About Our Journey

A Q&A Session With Nithiya Ananthakirishnan, CEO - Algorics Read More

Our Growth Story At Algorics

Author: Parul Mathur (Assistant Manager - Operations) Read More

COVID-19: The impact on Oncology Patients and Trials

Author: Priya Govindasamy- Director, Biostatistics & Programming Read More

“KEY-NOTE SPEECH”- Suresh Ramu

The burden of Cancer is expected to be touching 24 million new cases in the next 20 years. Even though the cases are increasi... Read More

“CAUSAL INFERENCE AND MACHINE LEARNING FOR PHARMA REAL WORLD DATA”- Dr. Vikas Ramachandra

One of the biggest problems faced by machine learning today is that so much of real-world data is not generated in a way whi... Read More

“CANCER RESEARCH STATISTICS- AN INDIAN PERSPECTIVE”-Dr. Jayanti Gupta

Talking about the Cancer burden in the country, India has the third highest number of cancer cases and over a million new cas... Read More

“ROLE OF STATISTICAL PROGRAMMER IN ONCOLOGY CLINICAL TRIAL REPORTING”- Hanumantha Rao Karedla

Clinical Trials in oncology are somewhat more complicated than other therapeutic areas, A tremendous amount of research condu... Read More

“ROLE OF BIOSTATISTICS IN ONCOLOGY DRUG DEVELOPMENT”- Veena Vincent

An increased incidence of cancer in the world has led to an increase in Oncology research. Clinical research is a critical co... Read More

“CLINICAL PHARMACOLOGY IN ONCOLOGY CLINICAL TRIALS”- Chandrasekhar Bhupathi

The study of Clinical Pharmacology (CP) is a vital part of the drug development process. The purpose of CP trials is to study... Read More

Statistical methods for handling missing data in clinical trials during COVID-19

With the ever-increasing number of clinical trials (the gold standard in new therapy evaluation) including those relating to ... Read More

Algorics announces MetaVate, their unique automated end-to-end data standardization and transformation platform, is now available as standard for all customers

New Jersey – 3rd September, 2020. Algorics a data focused biometrics service provider, today announced the release of Read More

Statistical considerations for ongoing clinical trials during COVID-19 crisis.

From this webinar you will learn: Insights derived from www.clinicaltrials.gov data to showcase the impact of COVID-19 on on... Read More

Macro-level impact of COVID on the clinical research industry.

I hope you and your family are well and safe during this time of the COVID crisis. With the rapid spread of COVID-19 all o... Read More